Population pharmacokinetics of valganciclovir prophylaxis in paediatric and adult solid organ transplant recipients-Reference-Cited by-同舟云学术

Population pharmacokinetics of valganciclovir prophylaxis in paediatric and adult solid organ transplant recipients

Published:2014-07-21 Issue:2 Volume:78 Page:343-352
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Vezina Heather E.¹²,Brundage Richard C.¹,Balfour Henry H.³⁴

Affiliation:

1. Department of Experimental and Clinical Pharmacology; University of Minnesota; College of Pharmacy; Minneapolis Minnesota United States

2. Department of Pediatrics; Division of Clinical Pharmacology and Therapeutics; The Children's Hospital of Philadelphia; Philadelphia Pennsylvania United States

3. Medical School; Department of Laboratory Medicine and Pathology; University of Minnesota; Minneapolis Minnesota United States

4. Medical School; Department of Pediatrics; University of Minnesota; Minneapolis Minnesota United States

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

University of Minnesota Graduate School

University of Minnesota International Center for Antiviral Research and Epidemiology

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12343/fullpdf

Reference41 articles.

1. In vitro susceptibility of cytomegalovirus isolates from immunocompromised patients to acyclovir and ganciclovir;Cole;Diag Microbiol Infect Dis,1987

2. Prolonged inhibitory effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against replication of Epstein-Barr virus;Lin;J Virol,1984

3. Cytomegalovirus disease in high-risk transplant recipients despite ganciclovir or valganciclovir prophylaxis;Akalin;Am J Transplant,2003

4. Efficacy and safety of low-dose valganciclovir for prevention of cytomegalovirus disease in renal transplant recipients: a single-center, retrospective analysis;Gabardi;Pharmacotherapy,2004

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of patients’ characteristics associated with the efficacy and safety of oral valganciclovir treatment for infants with symptomatic congenital cytomegalovirus disease;Journal of Infection and Chemotherapy;2024-10

2. Pharmacokinetic and Pharmacodynamic Assessment of Valganciclovir in Infants With Congenital Cytomegalovirus Infection;Therapeutic Drug Monitoring;2024-09-04

3. Challenges for the improvement of valganciclovir prophylaxis in solid organ transplantation and the possible role of therapeutic drug monitoring in adults;British Journal of Clinical Pharmacology;2024-06-18

4. Trough ganciclovir concentration as predictor of leukopenia in lung transplant recipients receiving valganciclovir prophylaxis;Transplant Infectious Disease;2023-08-28

5. Establishment and Evaluation of a Parametric Population Pharmacokinetic Model Repository for Ganciclovir and Valganciclovir;Pharmaceutics;2023-06-23